herenciageneticayenfermedad: Groundbreaking automated genomic workflow adaption

martes, 21 de noviembre de 2017

Groundbreaking automated genomic workflow adaption

	November 20, 2017
	Genomics
	The latest genomics news from AZoNetwork

Groundbreakingautomated genomic workflow adaption
Fluent provides groundbreaking adaptation to a variety of genomic workflow applications, including nucleic acid extraction, PCR set- up, sequencing library preparation including normalization and quantification, to ensure comprehensive automation of every genomic workflow. Innovative technology provides superior reliability and precision, allowing for processing high throughput runs, with longer walkaway times.

Learn More

			Mysterious DNA modification appears more in the brain under stress With advances in genomics, scientists are discovering additional components of the DNA alphabet in animals. Do these unusual chemical modifications of DNA have a special meaning, or are they just signs that cellular machines are making mistakes?

			‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the world's more diverse populations, according to a study led by the Translational Genomics Research Institute, an affiliate of City of Hope, and the Keck School of Medicine of the University of Southern California.

	AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

	Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment for these patients in real-time.

	New genomics study aims to evaluate effectiveness of blood test in detecting breast cancer Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.

	Micronic's 0.30 ml Tubes External Thread To address the need for low volume genomics, the 0.30 ml tube enables miniaturization of reaction volume required in genomic applications. The automation friendly tube cuts out intermediate (screening) plates and is more accessible for low volume liquid handlers.